IP Library Granted Patent US 10,436,700
Granted Patent B1
US 10,436,700 · App. 16/513,580 · Granted Oct 8, 2019

Cell capture system and method of use

Inventors: Kalyan Handique (Plymouth, MI); Pridyadarshini Gogoi (Plymouth, MI); Christopher Siemer (Plymouth, MI); Saedeh Sepehri Javdani (Plymouth, MI)
Assignee: Celsee Diagnostics, Inc.
G01N15/1484B01L3/021B01L3/502715B01L3/502746B01L3/502761C12M47/04G01N1/20G01N1/28G01N1/40G01N1/405B01L2200/0652B01L2200/0668B01L2300/0636B01L2300/0654B01L2300/0672B01L2300/0816B01L2300/0819B01L2300/0848B01L2300/0877B01L2300/168B01L2400/086G01N1/4077G01N2015/0065G01N2015/1006G01N2015/149G01N2035/00158G06K9/00127
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 10,436,700
App. No.
16/513,580
Granted
Oct 8, 2019
Kind
B1
Abstract

A cell capture system including an array, an inlet manifold, and an outlet manifold. The array includes a plurality of parallel pores, each pore including a chamber and a pore channel, an inlet channel fluidly connected to the chambers of the pores; an outlet channel fluidly connected to the pore channels of the pores. The inlet manifold is fluidly connected to the inlet channel, and the outlet channel is fluidly connected to the outlet channel. A cell removal tool is also disclosed, wherein the cell removal tool is configured to remove a captured cell from a pore chamber.

Claims (32)

1. A system for isolating and analyzing a set of target particles from a biological sample, comprising:

a substrate comprising a set of chambers at a first broad surface, wherein each chamber in the set of chambers is configured to retain a single target particle of the set of target particles and comprises:

a set of walls defining a chamber volume, a chamber length, and a chamber cross-section; and

an open surface permitting access of the single target particle to the chamber volume from a direction perpendicular to the broad surface of the substrate;

an optical element disposed adjacent to the set of chambers, wherein the optical element is configured to direct light transmitted through at least one of the first broad surface and a second broad surface opposing the first broad surface, into the set of chambers;

an inlet channel positioned superior the set of chambers and directly fluidly coupled to the set of chambers, whereby fluid received at the inlet channel is configured to concurrently access each of the chambers in the set of chambers at the open surface of each chamber, wherein fluid received at the inlet channel enters each chamber only by way of the open surface of each chamber; and

a fluid network fluidly coupled to the inlet channel, wherein the fluid network is configured to distribute a reagent fluid in a direction substantially parallel to the broad surface through the inlet channel, permitting access of the reagent fluid to the set of chambers.

2. The system of claim 1 , wherein the substrate is optically transparent, and wherein each chamber of the set of chambers is individually optically accessible from a direction perpendicular to the broad surface of the substrate.

3. The system of claim 1 , wherein the set of chambers comprises more than 200,000 chambers.

4. The system of claim 1 , wherein the set of target particles comprise a set of cells co-captured with a set of functionalized microspheres, as a set of complexes.

5. The system of claim 4 , wherein the set of functionalized microspheres comprises a set of magnetic microspheres.

6. The system of claim 1 , wherein the optical element comprises at least one of a light reflector, a microlens, a light collimator, a filter, and an diffuser.

7. The system of claim 1 , wherein the reagent fluid distributed by the fluid network is configured for processing the biological sample for at least one of: a single cell proteomic analysis, a nucleic acid analysis, and a genomic sequencing process.

8. The system of claim 1 , wherein the chamber length of each chamber prevents egress of the single target particle due to fluid crossflow at the intersection between the inlet channel and the open surface of the chamber.

9. The system of claim 2 , further comprising an imaging subsystem positioned at a first side of the substrate and oriented in a direction perpendicular to the broad surface of the substrate.

10. The system of claim 3 , further comprising a stage configured to align a selected chamber of the of the set of chambers with an objective of the imaging subsystem.

11. The system of claim 1 , wherein each chamber of the set of chambers is fluidly isolated from an adjacent chamber by the set of walls of each chamber.

12. The system of claim 1 , wherein the chamber cross-section of each chamber in the set of chambers is arranged parallel to the broad face of the substrate, and wherein the cross-section of each chamber in the set of chambers defines a polygon.

13. The system of claim 1 , further comprising a reagent cartridge comprising a set of compartments, wherein each of the set of compartments contains one of a set of reagent fluids, wherein each compartment of the reagent cartridge stores a different reagent fluid.

14. The system of claim 1 , further comprising a pumping subsystem system configured to couple to the inlet channel, wherein the pumping subsystem provides a pumping pressure at the inlet channel to promote a controlled flow rate of the reagent fluid through the inlet channel.

15. A system for isolating and analyzing a set of target particles from a biological sample, comprising:

a substrate comprising a set of chambers and a broad face, wherein each chamber in the set of chambers is configured to retain a single target particle of the set of target particles and comprises:

a set of walls defining a chamber volume and a chamber cross-section; and

an open surface permitting access of the single target particle to the chamber volume from a direction perpendicular to the broad surface of the substrate;

an optical element disposed adjacent to the set of chambers of the substrate, wherein the optical element is configured to direct light into the set of chambers;

an inlet channel positioned superior the set of chambers and directly fluidly coupled to the set of chambers, whereby fluid received at the inlet channel is configured to concurrently access each of the chambers in the set of chambers at the open surface of each chamber, wherein fluid received at the inlet channel enters each chamber only by way of the open surface of each chamber; and

a fluid network comprising a set of branches fluidly coupled to the inlet channel, wherein the fluid network is configured to distribute a reagent fluid in a direction substantially parallel to the broad surface through the inlet channel, permitting access of the reagent fluid to the set of chambers.

16. The system of claim 15 , wherein the set of target particles comprise a set of cells co-captured with a set of functionalized microspheres, as a set of complexes, and wherein wherein the set of functionalized microspheres comprises a set of magnetic microspheres.

17. The system of claim 16 , wherein the chamber volume of each chamber prevents egress of the single target particle due to fluid crossflow at the intersection between the inlet channel and the open surface of the chamber.

18. The system of claim 17 , wherein the chamber cross-section of each chamber in the set of chambers is arranged parallel to the broad face of the substrate, and wherein the cross-section of each chamber in the set of chambers defines a polygon.

19. The system of claim 15 , wherein each chamber of the set of chambers is fluidly isolated from an adjacent chamber by the set of walls of each chamber.

20. The system of claim 15 , wherein the reagent fluid distributed by the fluid network is configured for processing the biological sample for at least one of: a single cell proteomic analysis, a nucleic acid analysis, and a genomic sequencing process.

Assignments (4)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 5, 2020
From: CELSEE, INC.
To: BIO-RAD LABORATORIES, INC.
Reel/Frame 054269/0742 →
CHANGE OF NAME Recorded Sep 24, 2020
From: CELSEE DIAGNOSTICS, INC.
To: CELSEE, INC.
Reel/Frame 053881/0555 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jul 16, 2019
From: HANIDQUE, KALYAN; GOGOI, PRIYADARSHINI; SIEMER, CHRISTOPHER; JAVDANI, SAEDEH SEPEHRI
To: DENOVO SCIENCES, INC.
Reel/Frame 049769/0939 →
CHANGE OF NAME Recorded Jul 16, 2019
From: DENOVO SCIENCES, INC.
To: CELSEE DIAGNOSTICS, INC.
Reel/Frame 049772/0050 →
Continuity (8)
Continuation 16443140 · Jun 17, 2019
Continuation 16419254 · May 22, 2019
Continuation 16048104 · Jul 27, 2018
Continuation 15657553 · Jul 24, 2017
Continuation 15333420 · Oct 25, 2016
Continuation 14607918 · Jan 28, 2015
Continuation 13557510 · Jul 25, 2012
Provisional Application 61513785 · Aug 1, 2011
Cited By (3)
US 12,259,392 US 12,504,378 US 12,643,103